VGR-R01

· Shanghai Vitalgen BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VGR-R01, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy [Phase 1]